Alzamend Neuro, Inc. (ALZN): Insider Trading, Congress Trades & Research | Tormere

ALZN

$1.13-0.88%download financials (.py)

Alzamend Neuro, Inc.

Market Cap

$5M

Live price × shares (2026-10-16)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

0.29

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jul 2026 · negative earnings

P/S (TTM)

—

Price / TTM revenue

P/B

0.9

Price / stockholders equity

EV/EBITDA

—

TTM

Price Chart

Loading…

Signals

Insider Velocity

purchases / sales, 90d

Market & Alt Data

News

15

recent articles

Analyst Consensus

Strong Buy

7 analysts

Velocity Score

7.05x

Avg Daily Selling (90d)

22.2 sh/day

Baseline Daily Selling

7.6 sh/day

Unique Sellers (90d)

1

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-26	2026-08-31	AULT MILTON C III	Director	Sale	2,000	$1.56	$3K	0	View
2026-04-14	2026-04-16	AULT MILTON C III	Director	Purchase	108.4K	$1.00	$109K	116.6K	View
2025-12-23	2025-12-30	AULT MILTON C III	Director	Sale	1,851	$2.07	$4K	0	View
2025-10-09	2025-10-10	AULT MILTON C III	Director	Sale	20.4K	$2.32	$47K	8,260	View
2025-10-08	2025-10-10	AULT MILTON C III	Director	Sale	101.4K	$2.44	$247K	28.7K	View

1–5 of 25

1 / 5

Recent News

Alzamend Neuro (ALZN) Rises 4.26% to $1.34 as Shares Press Toward Range Resistance - Flat Correction

https://www.siam.in/ · 2026-10-19

Alzamend Neuro (ALZN) Rises 4.26% to $1.34 as Shares Press Toward Range Resistance - Volume Nodes

https://www.dars.gov.et/ · 2026-10-19

Alzamend Neuro (ALZN) Edges Lower to $1.34 as Shares Sit Near Lower Support - Institutional Sentiment

siam.in · 2026-10-14

No shares sold: Alzamend Neuro (ALZN) requests withdrawal of a resale registration.

Stock Titan · 2026-10-09

Alzamend Neuro (ALZN) Upgraded to Buy: What Does It Mean for the Stock?

Yahoo Finance · 2026-10-08

Is Centene (CNC) Stock Outpacing Its Medical Peers This Year?

Yahoo Finance · 2026-09-22

Alzamend Neuro Regains Compliance with Nasdaq Listing Standards

Yahoo Finance · 2026-09-16

Alzamend Neuro's Phase 1/2A Lithium Neuroimaging Data Accepted for Poster Presentation at Neuroscience 2026 in Washington, DC

Yahoo Finance · 2026-08-20

Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain

Yahoo Finance · 2026-08-18

Alzamend Neuro Announces Initial Closing of Securities Purchase Agreement with Ault Lending

Yahoo Finance · 2026-08-04

ALZN Forecast — Price Target — Prediction for 2027

TradingView · 2026-06-26

Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study in a Trial Conducted at Massachusetts General Hospital

Yahoo Finance · 2026-04-07

Alzamend Neuro Reports Positive Topline Data from Phase II Clinical Trial of AL001 "Lithium in Brain" Study; AL001 Achieves Bioequivalence and Demonstrates Superior Brain Delivery Across All Measured Brain Regions

Yahoo Finance · 2026-03-26

Alzamend Neuro (ALZN) Stock Forum and Discussion

Moomoo · 2025-07-10

What is the current Price Target and Forecast for Alzamend Neuro (ALZN)

Zacks Investment Research · 2023-05-10

Informational purposes only, not investment advice.

Recent Insider Activity (Form 4) — Last 5

Date	Insider	Type	Shares	Value
2026-08-26	AULT MILTON C III	S	2,000	$3,116.2
2026-04-14	AULT MILTON C III	P	108,388	$108,897.42
2025-12-23	AULT MILTON C III	S	1,851	$3,825.09
2025-10-09	AULT MILTON C III	S	20,397	$47,390.39
2025-10-08	AULT MILTON C III	S	101,394	$247,158.01